🔗 Share this article

An underground market for unapproved weight-loss medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Drug Acquiring Popularity Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these profiles privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of next-day British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Concerns

Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to individuals administering products of unknown origin.

Several experts said the demand for retatrutide could be connected to the rising cost of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer regulations, risking fines, prosecution or prison.

Platform Response and Content Removal

Based on the social media company, the service has taken down violative content and banned associated hashtags and search suggestions. The company stated it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.

Online Trading Operations

Investigations also found groups with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, filled with photos of slimming results, positive reviews and detailed instructions for mixing or injecting at residence.

Within minutes of entering one community, a vendor posted contact information, where most transactions occur. The vendor sent an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Inside these groups, messages display dark colored packages with postal service labels, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for Telegram stated it regularly moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are administering substances they can’t verify. Even if the science behind this drug is valid, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to potentially significant health risks”.